Anthony A. Florence Jr. has bought stock on 35 days since Jan 2016
10% owner at Korro Bio, Inc., and 20 other companies
SEC CIK 0001559827 · Filings on SEC.gov ↗
Anthony A. Florence Jr.'s record
3 months after each buy, from the first price a copier could get.
6 buys since 2016 with 3 months of prices.
Companies
- KRRO Korro Bio, Inc.10% owner
- SGP SpyGlass Pharma, Inc.10% owner
- MBX MBX Biosciences, Inc.10% owner
- SVRA Savara Inc.10% owner
- GNCA Genocea Biosciences, Inc.10% owner
- TRVI Trevi Therapeutics, Inc.10% owner
- HOOD Robinhood Markets, Inc.Director
- MTCR Metacrine, Inc.10% owner
- MRKR Marker Therapeutics, Inc.10% owner
- RGLS Regulus Therapeutics Inc.10% owner
- AKUS Akouos, Inc.10% owner
- MRSN Mersana Therapeutics, Inc.10% owner
- CSPR Casper Sleep Inc.Director and 10% owner
- ADAP Adaptimmune Therapeutics Plc10% owner
- AVEO Aveo Pharmaceuticals, Inc.10% owner
- SURF Surface Oncology, Inc.10% owner
- TCON Tracon Pharmaceuticals, Inc.10% owner
- ABIO Arca Biopharma, Inc.10% owner
- APPN Appian Corporation10% owner
- ILIU Interleukin Genetics Inc10% owner
- ARDX Ardelyx, Inc.10% owner
Every filing
42 filings since Jan 2016, newest first
Korro Bio, Inc.
10% owner
Spyglass Pharma, Inc.
10% owner
Mbx Biosciences, Inc.
10% owner
Korro Bio, Inc.
10% owner
Savara Inc
10% owner
Genocea Biosciences, Inc.
10% owner
Trevi Therapeutics, Inc.
10% owner
Robinhood Markets, Inc.
Director
Metacrine, Inc.
10% owner
Marker Therapeutics, Inc.
10% owner
Regulus Therapeutics Inc.
10% owner
Akouos, Inc.
10% owner
Mersana Therapeutics, Inc.
10% owner
Casper Sleep Inc.
Director and 10% owner
Adaptimmune Therapeutics Plc
10% owner
Trevi Therapeutics, Inc.
10% owner
Regulus Therapeutics Inc.
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Adaptimmune Therapeutics Plc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Aveo Pharmaceuticals Inc
10% owner
Surface Oncology, Inc.
10% owner
Aveo Pharmaceuticals Inc
10% owner
Adaptimmune Therapeutics Plc
10% owner
Tracon Pharmaceuticals, Inc.
10% owner
Adaptimmune Therapeutics Plc
10% owner
Arca Biopharma, Inc.
10% owner
Appian Corp
10% owner
Appian Corp
10% owner
Mersana Therapeutics, Inc.
10% owner
Aveo Pharmaceuticals Inc
10% owner
Adaptimmune Therapeutics Plc
10% owner
Interleukin Genetics Inc
10% owner
Ardelyx, Inc.
10% owner
Ardelyx, Inc.
10% owner
About Anthony A. Florence Jr.
Anthony A. Florence, Jr. is a venture capital executive serving as a 10% owner of SpyGlass Pharma, Inc. (SGP), a late-stage biopharmaceutical company developing sustained drug delivery systems for chronic eye conditions.( He filed a Form 3 reporting indirect holdings in multiple series of preferred stock convertible into over 2.5 million common shares, owned directly by New Enterprise Associates (NEA) funds, where he holds managing roles at their general partners.( Florence recently participated in a directed share purchase of approximately 937,500 shares at $16 per share on February 9, 2026, alongside other insiders.(
Florence is affiliated with New Enterprise Associates, a prominent venture capital firm, as indicated in SEC filings listing him among managing directors or partners who granted power of attorney for filings.( His address is listed as 104 5th Avenue, 19th Floor, New York, NY 10011.( With an estimated net worth exceeding $3.4 billion as of early 2026, Florence has significant investments across public companies, including a director role at Robinhood.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.